help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ang, C.
Right arrow Articles by Lumsden, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ang, C.
Right arrow Articles by Lumsden, M. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 10 4939-4942
Copyright © 2001 by The Endocrine Society


Other Original Articles

The Effect of Type 1 Diabetes Mellitus on Vascular Responses to Endothelin-1 in Pregnant Women

C. Ang, C. Hillier, A. D. Cameron, I. A. Greer and M. A. Lumsden

Department of Obstetrics and Gynecology, University of Glasgow, and Vascular Assessment Unit, Glasgow Caledonian University (C.H.), Glasgow, United Kingdom G3 8SJ

Address all correspondence and requests for reprints to: Dr. M. A. Lumsden, University Department of Obstetrics and Gynecology, Queen Mother’s Hospital, Glasgow, United Kingdom G3 8SJ. E-mail: malumsden{at}clinmed.gla.ac.uk

Abstract

Diabetes is associated with vascular dysfunction, which may be due in part to altered vascular responses to endogenous peptides such as endothelin-1. These altered responses may also contribute to the decreased maternal peripheral resistance in pregnancy. The aim of this study was to examine the effect of diabetes on the vasoconstrictor response to endothelin-1 in pregnant women.

Small arteries were isolated from nine healthy pregnant, seven type 1 diabetic pregnant women, and five healthy nonpregnant women. Contraction curves were performed on a wire myograph for noradrenaline (1 nM to 30 µM) and endothelin-1 (1 pM to 0.3 µM). Maximum responses and sensitivity were compared by t test.

No differences in maximum response to noradrenaline or potassium were seen among the three groups. The maximum response to endothelin-1 was significantly increased in pregnancy (P < 0.05), whereas endothelin-1 sensitivity was reduced in the diabetic compared with the nondiabetic pregnant women (P < 0.05).

Pregnant women have an increased maximum vasoconstriction response to endothelin-1 compared with nonpregnant women, whereas diabetic pregnant women demonstrate reduced sensitivity to endothelin-1. These observations suggest that endothelin-1 may play a role in maintaining peripheral vascular tone in normal pregnancy, and the decreased sensitivity seen in pregnant women with diabetes may reflect abnormal vascular reactivity.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Sharma, L. Deelman, M. Madesh, B. Kurz, E. Ciccone, S. Siva, T. Hu, Y. Zhu, L. Wang, R. Henning, et al.
Involvement of transforming growth factor-{beta} in regulation of calcium transients in diabetic vascular smooth muscle cells
Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1258 - F1270.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society